供应WHO09/242可溯源纤维蛋白原B国际标准物质
产品详情如下，更多产品价格和货期，请咨询客服！
The 2nd International Standard for Fibrinogen Concentrate, consists of ampoules, coded 09/242, containing aliquots of a freeze-dried concentrate of fibrinogen prepared from human plasma. This preparation was established by the Expert Committee on Biological Standardization of the World Health Organization in October 2012, with labelled contents for Clottable Protein and Total Protein. Details of the preparation and value assignment are available in the document WHO/BS/2012.2208,(available from WHO). This standard is primarily intended to be used to calibrate secondary and/or in-house working fibrinogen concentrate standards.
This preparation is not for administration to humans or animals in the human food chain. WHO09/242
The preparation contains material of human origin, and either the final product or the source materials, from which it is derived, have been tested and found negative for HBsAg, anti-HIV and HCV RNA. As with all materials of biological origin, this preparation should be regarded as potentially hazardous to health. It should be used and discarded according to your own laboratory’s safety procedures. Such safety procedures should include the wearing of protective gloves and avoiding the generation of aerosols. Care should be exercised in opening ampoules or vials, to avoid cuts. 可溯源纤维蛋白原B国际标准物质
纤维蛋白原浓缩物的第二个国际标准由安瓿组成，编号09/242，包含从人血浆制备的纤维蛋白原冻干浓缩物的等分试样。该制剂由世界卫生组织生物标准化专家委员会于2012年10月建立，含有可封闭蛋白和总蛋白的标签内容物。有关准备和价值分配的详细信息，请参阅文件世界卫生组织/BS/2012.2208（可从世界卫生组织获得）。本标准主要用于校准二级和/或内部工作的纤维蛋白原浓缩物标准。
该制剂不适用于人类或人类食物链中的动物。
该制剂含有人类来源的材料，其最终产物或来源材料经过测试，发现HBsAg、抗HIV和HCV RNA呈阴性。与所有生物来源的材料一样，这种制剂应被视为对健康有潜在危害。应根据您自己实验室的安全程序使用和丢弃它。此类安全程序应包括佩戴防护手套和避免产生气溶胶。打开安瓿或小瓶时应小心，以避免割伤。